Clinical Trial Update: Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease [NA]

View source ↗

Summary

This clinical trial is evaluating combined subthalamic nucleus and nucleus basalis of Meynert deep brain stimulation for mild cognitive impairment in Parkinson'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Parkinson Disease

Drugs mentioned

• Deep Brain Stimulation (Subthalamic Nucleus + Nucleus Basalis of Meynert)

Snippet

Sponsor: Helen M. Bronte-Stewart | Conditions: Parkinson's Disease, Mild Cognitive Impairment | NA | Status: RECRUITING